ArticleFamilial cancer2026
Endoscopic prediction model for detecting advanced rectal polyps after ileorectal anastomosis in familial adenomatous polyposis: a dual-center retrospective study.
Article in Familial cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Familial adenomatous polyposis (FAP) patients who undergo ileorectal anastomosis (IRA) remain at risk for advanced rectal neoplasia. Early identification of polyps < 10 mm is crucial to prevent metachronous rectal cancer. This study aimed to develop an endoscopic prediction model using mucosal phenotypic features to identify advanced diminutive rectal polyps in FAP patients post-IRA. This dual-center retrospective study included 48 FAP patients who underwent IRA and endoscopic surveillance from 2018 to 2024. A total of 452 rectal polyps < 10 mm were evaluated using high-definition white-light endoscopy, NBI, dye-based chromoendoscopy, and magnifying endoscopy. Data from Center 1 were split into a training set (80%) and validation set (20%), while Center 2 served as an external validation cohort. Significant variables (P < 0.05) from univariate analysis were entered into multivariable logistic regression. In the overall cohort and the APC pathogenic mutation subgroup, nomograms were developed and evaluated using ROC curves, calibration curves, and decision curve analysis (DCA). Independent predictors of advanced polyps included chicken-skin mucosa (OR = 2.50, P < 0.01), JNET type 2 A-2B low (OR = 3.39, P < 0.01), erosion/ulceration (OR = 1.68, P = 0.02), and pit pattern III-L/IV (OR = 2.47, P < 0.01). The nomogram showed good discriminative ability with AUCs of 0.822 (training), 0.806 (internal validation), and 0.815 (external validation). Separate prediction models were developed for all IRA-postoperative FAP patients and the APC pathogenic mutation subgroup, integrating four endoscopic features to accurately identify advanced diminutive rectal polyps, thereby reducing the risk of malignancy in patients.
Indexed as
Identifiers
41874735What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.